hunter williams retatrutide microdosing Ozempic changed the conversation. Now obesity medicine experts are watching what could come next: Retatrutide. In this episode of unPAUSED, Dr. Michelle Gordon breaks down why researchers are so excited about this The Impact of Glucagon-like Peptide-1

Other safety areas under investigation include: Lean muscle mass preservation significant weight loss can result in loss of muscle tissue, and researchers are monitoring body composition changes Bone density a consideration with rapid weight loss in general Thyroid C-cell effects a class concern for GLP-1 receptor agonists, though clinical significance in humans remains uncertain [13] Pancreatitis and gallbladder disease signals observed across the incretin class are being monitored for retatrutide, though no established causal link has been confirmed for this agent specifically Dehydration and kidney function prolonged vomiting or diarrhoea can lead to dehydration and, in some cases, acute kidney injury

Combined with the two fiber sources to support the satiety and appetite suppression many dieters want, and we have a powerhouse supplement

But the moment you reintroduce liquid, you're bringing that delicate structure back to life, and it's incredibly vulnerable

Yes, often and the reason is rooted in how these medications work

Doyle ME, Theodorakis MJ, Holloway HW, Bernier M, Greig NH, Egan JM

Pharmacokinetics and pharmacodynamics of a new GLP-1 agonist AVE0010 in type 2 diabetes patients